Regulatory News: Ikonisys SA (Paris:ALIKO) (Code ISIN: FR00140048X2 Mnémonique: ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution
The Ikoniscope20 performs immune monitoring functions more effectively, easily and competitively than conventional flow cytometers (the standard tool used for such detection) The Ikoniscope20
The Ikoniscope20 has been successfully installed at Toma Advanced Biomedical Assays and being used for daily workflow for the patient care TomaLab will act as a Reference Laboratory for Ikonisys